Changsong Qi

机构：Peking University, Peking University Cancer Hospital · ORCID：0000-0001-9157-3768

发表论文 134 篇 · 总被引 3637 次 · h-index 29

代表论文

• Optimizing CAR T cell therapy for solid tumours: a clinical perspective (2025 · Nature Reviews Clinical Oncology · 被引 29)
• A bispecific antibody–drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trial (2025 · Nature Medicine · 被引 19)
• Impact of concomitant medications on efficacy of CLDN18.2-specific CAR-T cell therapy in advanced gastric cancer (2025 · British Journal of Cancer · 被引 3)
• TPM3–NTRK1 fusion confers resistance to osimertinib in lung adenocarcinoma: a model in a continuous cell line (2025 · Human Cell · 被引 3)
• Immune and genetic landscapes of biliary atresia: a pathway to precision medicine (2025 · BMC Pediatrics · 被引 3)
• Data from Allogeneic B7-H3–Targeted CAR Vδ1T-cell Therapy in Advanced Solid Tumors: A Phase I Study (2026 · 被引 1)